Trial intelligence / Profile preview

Esketamine during the perioperative period for thoracoscopic rib fracture fixation

ChiCTR2000040184Phase 4Recruiting

Sponsor
Xiang'an Hospital of Xiamen University
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in rib fracture (2 arms), sponsored by Xiang'an Hospital of Xiamen University. Primary endpoints: Mean arterial pressure, Heart rate and 11 more. Started Dec 2020; status: recruiting.

02

Drugs

esketamine
03

Conditions

rib fracture

Beyond the preview

Go deeper on ChiCTR2000040184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call